Optometrists in Allendale, MI Accepting Medicare

7 Optometrists found. Showing 1 - 7

Dr. Nicholas Vijay Lillie, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6101 Lake Michigan Dr, Suite B 700, Allendale, MI 49401 Phone: 616-895-2020    Fax: 616-895-2060

Dr. Austin Loshinskie, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11301 Commerce Dr Ste A, Allendale, MI 49401 Phone: 616-895-9550

Sensory Learning Center Of West Michigan Optometrist - Vision Therapy Medicare: Not Enrolled in Medicare Practice Location: 11301 Commerce Dr, Suite A, Allendale, MI 49401 Phone: 616-895-9550    Fax: 616-892-5166

Allendale Family Vision Llc Optometrist Medicare: Medicare Enrolled Practice Location: 6101 Lake Michigan Dr, Allendale, MI 49401 Phone: 616-895-2020    Fax: 616-895-2060

Dr. Richard Thomas Conflitti, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 11301 Commerce Dr, Ste. A, Allendale, MI 49401 Phone: 616-895-9550    Fax: 616-892-5166

Dr. Patricia Marie Roslund, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11301 Commerce Dr, Ste. A, Allendale, MI 49401 Phone: 616-895-9550    Fax: 616-892-5166

Allendale Eye Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 11301 Commerce Rd., Suite A, Allendale, MI 49401 Phone: 616-895-9550    Fax: 616-892-5166

News Archive

New material identifies cancer cells and mounts a surprising attack

Many people across the globe are working hard to get the better of cancer; however cancer is always working too. Cancer cells can become resistant to the methods that have been adopted to kill them, so identifying drugs that act in different ways is part of the push to outsmart this ubiquitous disease

New vaccine shows promise against toughest HIV strains

A new study reports successful immunization against a so-far invincible "death star" strain of an HIV-related laboratory virus (SIVmac239) and another tough strain. The new approach also achieves long-term protection with a single dose, showing that gene therapy could allow broad and durable protection, based on a modified form of the CD4 protein that allows HIV entry into human cells.

Savient Pharmaceuticals resubmits KRYSTEXXA BLA

Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.

World first - newborn receives xenon gas in bid to prevent brain injury

In a world first, xenon gas has been successfully delivered to a newborn baby in a bid to prevent brain injury following a lack of oxygen at birth. This pioneering technique was developed by Professor Marianne Thoresen of the University of Bristol and carried out at St Michael's Hospital, part of University Hospitals Bristol NHS Foundation Trust.

Read more Medical News

› Verified 6 days ago